drugset / Trial / NCT06780267

Clinical Study of HRS-2129 for Postoperative Analgesia in Orthopaedics

NCT06780267

Phase 1/2 Completed 199 enrolled Shandong Suncadia Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is being conducted to evaluate the safety, and efficacy of HRS-2129 for Postoperative analgesia in orthopaedics. To explore the reasonable dosage of HRS-2129 for Postoperative analgesia in orthopaedics.

Timeline

Start
2025-03-11
Primary completion
2026-03-19
Completion
2026-04-03

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-2129 Unknown
Comparator Tramadol Other / unclassified

Indications

No indication recorded.